Classical complement pathway
It is triggered by antigen-bound antibody molecules. (The only antibodies capable of binding are two units of IgG or one IgM. IgG4 cannot bind, but the other three IgG types can.) It is the binding of a specific part of the antibody molecule to the C1 component that initiates this pathway.
C1 and its subunits
This initial enzyme, C1, is a complex formed through a calcium-dependent association between two reversibly interacting subunits, C1q and C1 (C1qr2s2). Approximately 70% of C1 is at all times present in this complex form. C1 occurs in serum as a proenzyme which tends to undergo autoactivation but which is strictly controlled by C1-inhibitor (C1-In or C1 esterase). Upon the binding of C1 to immune complexes by virtue of the affinity of C1q for immunoglobulins (specifically IgM and IgG), the controlling action of C1-In is overcome and C1q effects activation of C1r2s2.
C1q possesses no intrinsic catalytic activity, but when any of several activators bind to the C1q subcomponent of C1, the homologous C1r and C1s subcomponents are converted into catalytically active species, namely C1r* and C1s*, triggering the first step of the classical pathway of complement activation.
Thus, on binding to immune complexes through C1q, the subunits of C1 become firmly associated and autoactivation commences even in the presence of the Cl-In.
Steps leading to C3-convertase
Initially, a conformational change in C1r occurs, followed by proteolytic activation which results in the cleavage of all four polypeptide chains of C1r2s2.
Immune system / Immunology
|Systems||Adaptive immune system vs. Innate immune system • Humoral immune system vs. Cellular immune system • Complement system (Anaphylatoxins) • Intrinsic immune system|
|Antibodies and antigens||Antibody (Monoclonal antibodies, Polyclonal antibodies, Autoantibody) • Allotype • Isotype • Idiotype • Antigen (Superantigen)|
|Immune cells||White blood cells (T cell, B cell, NK cell, Mast cell, Basophil, Eosinophil) • Phagocyte (Neutrophil, Macrophage, Dendritic cell) • Antigen-presenting cell • Reticuloendothelial system|
|Immunity vs. tolerance||Immunity • Autoimmunity • Allergy • Tolerance (Central) • Immunodeficiency|
|Immunogenetics||Somatic hypermutation • V(D)J recombination • Immunoglobulin class switching • MHC / HLA|
|Substances||Cytokines • Opsonin • Cytolysin|
|Other||Inflammation • Epitope (Hapten) • Cross-reactivity|
Proteins: complement system (C, L, A)
|Activators||CLA: C3-convertase - MAC (C6, C7, C8, C9) - L: Mannan-binding lectin - A: Factor P/Properdin|
|Enzymes||C: C1Q/C1R/C1S - C4 - C2 - CLA: C3 - C5 (C5a) - L: MASP1 - MASP2 - A: Factor B - Factor D|
|Inhibitors||CLA: C1-inhibitor - Decay accelerating factor - Factor I - CL: C4BP - A: Factor H|
|Complement receptors||CR1 - CR2 - CR3 - CR4 - CD11b/CD11c/CD18 - Anaphylatoxin (C3a, C5a)|
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies